youtube_live
Q3 2026 earnings • released • EPS beat +7.77% • Revenue beat +2.95%
See resultschevron_right
GH:NASDAQ
Guardant Health Inc
$ 153.43
arrow_downward
-8.99%(-15.15) 1D
$ 137.49
arrow_downward
-10.39% (-15.94)bedtimeAfter hours
Closed: 11-р сарын 5, 16:00:02 (GMT-5) · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GH...
Open
$ 165.00
High
$ 165.10
Low
$ 151.92
Mkt. cap
20.59 тэрбум
Avg. vol.
1.81 сая
Volume
4.08 сая
52-wk high
$ 191.01
52-wk low
$ 74.55
EPS
-$ 3.50
Beta
1.67
Shares outstanding
134.20 сая
No. of employees
2 мян
Open
$ 165.00
High
$ 165.10
Low
$ 151.92
Mkt. cap
20.59 тэрбум
Avg. vol.
1.81 сая
Volume
4.08 сая
52-wk high
$ 191.01
52-wk low
$ 74.55
EPS
-$ 3.50
Beta
1.67
Shares outstanding
134.20 сая
No. of employees
2 мян
News stories
From web sources and news partners
Yahoo Finance
·
17 минутын өмнө
What Guardant Health (GH) Said on Its Q3 Earnings Call
Zacks
·
1 цагийн өмнө
Guardant Health (GH) Reports Q3 Loss, Tops Revenue Estimates
Securities.io
·
2 цагийн өмнө
Guardant Health Lifts 2026 Revenue Outlook as Screening Surges
Profile
Guardant Health, Inc. is an American biotechnology company based in Palo Alto, California. Co-founders Helmy Eltoukhy and AmirAli Talasaz serve as co-chief executive officers. Wikipedia
About Guardant Health Inc
CEOHelmy Eltoukhy | AmirAli Talasaz
Employees2.5 мян
Founded2012
HeadquartersPalo Alto, Калифорни, Америкийн Нэгдсэн Улс
SectorHealth Care
IndustryHealth care provider
Websiteguardanthealth.com